Xeligekimab (GR 1501) is a humanized monoclonal antibody that specifically targets and neutralizes interleukin 17A (IL-17A), a key cytokine involved in the induction and maintenance of pro-inflammatory responses. By binding to IL-17A, Xeligekimab effectively inhibits the cytokine's interaction with its receptor, thereby disrupting the pro-inflammatory cascade. This antibody is utilized in research focused on inflammatory diseases to understand the role of IL-17A in disease pathology and to evaluate potential therapeutic interventions.
Xeligekimab (GR 1501) is a humanized monoclonal antibody that specifically targets and neutralizes interleukin 17A (IL-17A), a key cytokine involved in the induction and maintenance of pro-inflammatory responses. By binding to IL-17A, Xeligekimab effectively inhibits the cytokine's interaction with its receptor, thereby disrupting the pro-inflammatory cascade. This antibody is utilized in research focused on inflammatory diseases to understand the role of IL-17A in disease pathology and to evaluate potential therapeutic interventions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
